Risk factors for invasive epithelial ovarian cancer: Results from a Swedish case-control study

American Journal of Epidemiology

Volumn 156, Issue 4, 2002, Pages 363-373

  Riman, Tomas ^a,b,c   Dickman, Paul W ^b   Nilsson, Staffan ^a,c   Correia, Nestor ^b   Nordlinder, Hans ^c,d   Magnusson, Cecilia M ^b   Persson, Ingemar R ^b  

^a FALUN HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Case control studies; Contraceptives, oral; Histology; Hormone replacement therapy; Ovarian neoplasms; Reproductive history; Sterilization

Indexed keywords

ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT;

CANCER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CASE CONTROL STUDY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; MUCINOUS CARCINOMA; ORAL CONTRACEPTION; OVARIECTOMY; OVARY CANCER; PARITY; PREGNANCY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SWEDEN;

AGE FACTORS; CARCINOMA; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; ODDS RATIO; OVARIAN NEOPLASMS; OVARIECTOMY; PARITY; PEDIGREE; RISK FACTORS; SWEDEN;

EID: 0037103296     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwf048     Document Type: Article

References (60)

1. Estimates of the worldwide incidence of eighteen major cancers in 1985
2. Benign ovarian cysts and ovarian cancer: A cohort study with implications for screening
3. Hormonal aspects of epithelial ovarian cancer: Review of epidemiological evidence
4. Reproductive factors and risk of ovarian cancer: A prospective study
5. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women
6. Parity, age at first childbirth, and risk of ovarian cancer
7. Parity, contraception, infertility, and the risk of epithelial ovarian cancer
8. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study
9. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer
10. A prospective study of reproductive factors and risk of epithelial ovarian cancer
11. Risk factors for ovarian cancer: A case-control study
12. Reproductive, genetic, and dietary risk factors for ovarian cancer
13. A case-control study of epithelial ovarian cancer
14. Lactation and the risk of epithelial ovarian cancer
15. Ovarian cancer: Incidence and case-control study
16. Determinants of ovarian cancer risk. I. Reproductive experiences and family history
17. Menopause and ovarian cancer
18. Tubal ligation and fatal ovarian cancer in a large prospective cohort study
19. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer
20. Surgical procedures associated with risk of ovarian cancer
21. Noncontraceptive estrogen use and epithelial ovarian cancer
22. Differences in risk factors for epithelial ovarian cancer by histologic type: Results of a case-control study
23. Hormone replacement therapy and risk of epithelial ovarian cancer
24. Effects of smoking on the development of female reproductive cancer
25. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: Results of a case-control study
26. Hereditary and familial ovarian cancer in southern Ontario
27. Factors affecting the association of oral contraceptives and ovarian cancer
28. Epithelial ovarian cancer and combined oral contraceptives
29. Incidence of ovarian cancer in relation to the use of oral contraceptives
30. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer
31. Incessant ovulation - A factor in ovarian neoplasia?
32. The etiology and prevention of ovarian cancer
33. Hereditary ovarian cancer: Molecular genetics and clinical implications
34. Epidemiologic evidence of uterine growth factors in the pathogenesis of ovarian cancer
35. Possible role of ovarian epithelial inflammation in ovarian cancer
36. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone
37. Risk factors for epithelial borderline ovarian tumors: Results of a Swedish case-control study
38. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy
39. Risk of endometrial cancer following estrogen replacement with and without progestins
40. Oral contraceptive health benefits: Perception versus reality
41. Agreement between women's histories of oral contraceptive use and physician records
42. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms
43. The reduction in risk of ovarian cancer associated with oral-contraceptive use
44. A quantitative assessment of oral contraceptive use and risk of ovarian cancer
45. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women
46. Retrograde menstruation in patients with endometriosis
47. Influence of heredity and environment on normal menstrual blood loss-a study of twins
48. Menstrual blood loss and body iron stores in Brazilian women
49. Perineal powder exposure and the risk of ovarian cancer
50. Genital talc exposure and risk of ovarian cancer
51. Pelvic inflammatory disease and the risk of epithelial ovarian cancer
52. Over-the-counter analgesics and risk of ovarian cancer
53. Histologic transformation of benign endometriosis to early epithelial ovarian cancer
54. Cancer risk after a hospital discharge diagnosis of endometriosis
55. The endometrium and endometriosis
56. A cytokine profile of normal and malignant ovary
57. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C-chemokines